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Summary
Introduction:  The  performance  of  second-generation  metal-on-metal  bearings  has  led  to  the
reintroduction  of  hip  resurfacing.  The  goal  of  this  multicentre  study  was  to  evaluate  the  short-
term radiological  and  clinical  outcomes  with  the  Durom  hip  resurfacing  system.
Hypothesis:  The  Durom  hip-resurfacing  system  will  have  similar  results  to  other  hip  resurfacing
systems and  traditional  hip  arthroplasty  implants.
Materials  and  methods:  In  the  four  participating  centers,  580  patients  (406  men,  174  women)
and 644  hips  were  included.  The  average  patient  age  was  48  years  (range  16—77).  A  posterolat-
eral surgical  approach  was  used  in  357  cases;  a  Hardinge-type  approach  was  used  in  182  cases
and a  Rottinger-type  approach  in  105.
Results:  After  an  average  follow-up  of  34  months,  31  hips  (4.8%)  had  been  revised.  The  rea-
sons for  revision  were  the  following:  10  (1.6%)  neck  fracture  (seven  with  Rottinger  operative
approach, one  with  Hardinge  approach  and  one  with  posterolateral  approach);  12  (1.9%)  femoral
loosening  (four  with  lateral  approach  and  eight  with  posterolateral  approach);  four  (0.6%)
acetabular  cup  migration;  three  (0.5%)  unexplained  pain;  one  (0.2%)  adverse  reaction  to  metal
debris; one  (0.2%)  infection.  Four  hips  (0.6%)  dislocated  but  without  recurrence  —  all  were
operated  using  the  Hardinge  approach.  The  613  hips  that  were  not  operated  on  again  had  sat-
isfactory clinical  results;  the  Merle  d’Aubigné  score  was  17.2  (range  12—18)  and  the  WOMAC
score was  91  (range  20—100).  The  ﬁve-year  survival  rate  was  91%  (95%  CI:  87—94%).  Based  on
radiographs,  the  average  cup  inclination  was  44.4◦ (range  30  to  70◦).  The  femoral  offset  was
reduced by  an  average  of  2.4  mm  (−31  to  23  mm)  and  the  leg  length  had  increased  by  an  aver-
age of  0.8  mm  (−15  to  19  mm)  relative  to  the  other  side,  which  was  prosthesis-free.  None  of
the non-revised  implants  showed  any  signs  of  loosening.
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Discussion:  This  multicentre  evaluation  revealed  that  the  Durom  revision  rate  was  slightly
higher than  the  rate  with  other  hip  resurfacing  systems  and  traditional  total  hip  arthroplasty.
Although  the  Durom  system  displayed  excellent  tribological  performance,  the  differences  rela-
tive to  other  implants  may  be  attributed  to  the  challenges  associated  with  impaction,  related  to
the geometry  and  design  of  the  cup,  and  to  precarious  primary  ﬁxation.  The  choice  of  surgical
exposure  and  implantation  technique  was  an  important  factor  in  the  survival  of  the  implant.
Level of  proof:  Level  IV  —  Retrospective  study.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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Statistical  methodsntroduction
ip  resurfacing  with  a  metal-on-polyethylene  bearing,  used
n  the  1970s,  only  had  a  75%  survival  rate  after  ﬁve  years
1].  This  was  secondary  to  polyethylene  wear  and  lead  to
his  implant  being  abandoned  in  the  1980s  [1].  The  per-
ormance  of  second-generation,  metal-on-metal  bearings  in
raditional  hip  implants  in  the  early  1990s  led  to  a  rebirth
f  the  hip  resurfacing  concept.  Hip  resurfacing  has  many
dvantages  relative  to  a  traditional  hip  arthroplasty:  bone
tock  is  preserved  [2],  anatomical  offset  and  leg  length  are
eproduced  [3],  physiological  joint  range  of  motion  is  main-
ained  [4],  excellent  functional  results  achieved  that  meet
ork  and  sports  requirements  [5—8],  joint  stability  is  better
9]  and  the  infection  rate  is  low  [10].  But  hip  resurfacing
lso  presented  speciﬁc  problems  such  as  neck  fracture  [11],
emoral  component  loosening  with  or  without  head  collapse
11—14]  and  adverse  reactions  to  metal  debris  produced  by
he  bearing  surfaces  (inﬂammation,  osteolysis,  pseudotu-
our  formation,  tissue  toxicity)  [15—17].
The  Durom  hip  resurfacing  system  (Zimmer,  Warsaw,  IN,
SA)  was  introduced  in  Europe  and  Canada  in  2003.  The
iggest  advantages  of  this  implant  was  that  it  had  the  same
ribological  features  that  made  the  MetasulTM (Zimmer,  War-
aw,  USA)  metal-on-metal  bearing  surfaces  successful:  high
arbon  content,  forged  Chrome-Cobalt  (Cr-Co)  alloy  with
ptimized  clearance  [18].  Its  excellent  tribological  perfor-
ance  was  conﬁrmed  by  the  low  amount  of  chromium  and
obalt  ions  released  into  the  blood  [19,20].  This  implant  has
peciﬁc  features  that  distinguish  it  from  other  available  hip
esurfacing  systems:  acetabular  cup  of  consistent  thickness
aving  the  shape  of  a  ﬂattened  dome  (165◦),  convex  sur-
ace  with  titanium  plasma  sprayed  coating  and  peripheral
ns.  The  femoral  component  geometry  allows  for  a  0.75-
o  1-mm  thick  cement  layer,  which  minimizes  pressure  and
voids  excessive  penetration  of  the  cement  into  the  femoral
ead.  The  smooth,  short  stem  has  no  mechanical  properties.
The  goal  of  this  study  was  to  evaluate  the  radiological  and
linical  results,  complication  rate  and  short-term  survival
ate  of  the  Durom  hip  resurfacing  system  based  on  a  large,
ulticentre  retrospective  study  comprising  nine  surgeons,
ne  of  whom  was  involved  in  the  design  of  the  system.
aterial and methods
atientshe  population  consisted  of  580  patients  who  had  under-
one  a  Durom  hip  resurfacing  procedure  performed  by  nine
T
surgeons.  Four  centres  participated,  with  one  centre  having
 single  surgeon  and  three  having  multiple  surgeons.  This
as  a  series  of  644  hips  that  included  the  learning  curves
or  all  the  surgeons  (Tables  1  and  2).  No  selection  criteria
ere  applied  and  the  cohort  represented  all  the  indications
ade  by  the  various  surgeons.
The  Durom  hip  resurfacing  system  was  implanted  accord-
ng  to  the  instructions  provided  by  the  manufacturer.  The
urom  system  has  the  following  speciﬁc  characteristics:  high
arbon  content,  forged  alloy  bearing  with  about  150  m
learance.  The  acetabular  cup  has  a  consistent  thickness,
he  shape  of  a  ﬂattened  dome  (165◦)  and  a  convex  surface
ith  titanium  plasma  sprayed  coating.  The  femoral  com-
onent  is  cemented  (0.75—1  mm  thick  layer).  Its  internal
urface  has  grooves  that  allow  the  cement  to  be  extruded
uring  insertion,  which  limits  pressurization  of  the  cement
n  the  bone.  The  smooth  femoral  stem  serves  as  an  alignment
uide.  The  femoral  head  is  inserted  about  3—4  minutes  after
he  cement  is  prepared.
ssessment  methods
he  clinical  evaluation  was  performed  before  the  surgery
nd  at  the  follow-up  using  the  Merle  d’Aubigné  (PMA)  func-
ional  score  [21]  and  the  Devane  et  al.  activity  score  [5].
n  addition,  the  WOMAC  score  was  determined  at  the  last
ollow-up  [22].
Anterior/posterior  X-rays  of  the  pelvis  at  the  follow-up
ere  examined  to  determine  the  implant  position  in  com-
arison  with  the  anatomical  features  of  the  contralateral
oint,  if  it  did  not  have  an  implant  (560  cases)  (Fig.  1).  The
adiography  analysis  sought  to  determine  if  the  cup  orien-
ation  had  changed  by  more  than  3◦ and  if  more  than  5  mm
igration  was  present,  as  these  were  considered  signs  of
oosening.  The  presence  of  radiolucent  lines  in  the  pelvis
23]  and  in  the  femur  zones  described  by  Amstutz  et  al.  [24]
as  assessed.  The  presence  of  osteolysis,  heterotopic  ossi-
cation  and  femoral  neck  narrowing  greater  than  10%  was
lso  recorded.  A  Dunn  view  of  the  operated  hip  was  used  to
etermine  the  anterior  femoral  offset.  The  latter,  given  in
illimetres,  is  the  distance  between  the  anterior  cortex  of
he  femoral  neck  and  the  most  anterior  part  of  the  femoral
omponent.he  entire  study  dataset  was  compiled  on  clinical  research
oftware  (Evamed-Etudes,  Evamed,  7,  rue  Alfred-Kastler,
Durom  hip  resurfacing  study  275
Table  1  Demographic  data  for  the  multicentre  series.
Number  of  patients  580  406  men  174  women
Number of  hips  644  448  men  196  women
Mean age  (min—max)  48  (16—77)
Diagnosis  for  hip  resurfacing  Primary
osteoarthritis
505  cases  (87%)
Osteonecrosis
35  cases  (6%)
Other
40  cases  (7%)
Body mass  index <  25:  324  (50%)  25—30:  229  (36%)  >  30:  91  (14%)
Table  2  Overall  series  data  on  the  revision  rate,  complication  rate  and  surgical  approach  for  each  participating  centre.
Number  of
surgeons
Number  of
cases  (644)
(%)
Approach  Number  of  revisions
(31)  and  %  per  centre
Number  of
dislocations  (%)
Number  of  femoral
neck  fractures  (10)
and  %  per  centre
Centre  1  3  265  (41.1)a Posterolateral  11  (4.1)  0  1  (0.4)
Centre 2 1  92  (14.4) Posterolateral 0  (0)a 0  0
Centre 3  2  182  (28.2)  Anterolateral
(Hardinge)
12  (6.6)  4  (2.1)a 2  (1.1)
Centre 4  3  105  (16.3)  Anterolateral
(Rottinger)
8  (7.6)  0  7  (6.6)a
•
•a Signiﬁcance: P < 0.05.
14000  Caen,  France).  Statistical  tests  were  performed  with
the  statistical  package,  R  (version  2.11.1).  An  alpha  level  of
0.05  was  used  to  determine  a  signiﬁcant  P-value.
The  differences  between  paired  samples  (PMA  and
WOMAC  before  surgery  vs.  at  follow-up)  were  analysed
with  a  paired  Student’s  t-test.  The  potential  relationship
between  various  factors  and  the  occurrence  of  implant  fail-
ure  (revision)  was  evaluated  by  two  methods:
Figure  1  Implant  positioning  (positive  values  indicate  limb  lengt
the average  lengthening  was  0.8  mm  (range  −15  to  19  mm)  and  th
The average  neck-shaft  angle  was  139◦ (range  112  to  158◦).  B.  On  th
(range −26  to  9  mm)  and  average  medialization  of  −0.7  mm  (−15  
70◦).  C.  Method  used  to  measure  the  anterior  offset;  the  average  m the  Chi2 test  was  used  to  evaluate  the  relationship
between  the  distribution  of  failures  and  gender,  preop-
erative  diagnosis  and  surgical  approach;
 Student’s  t-test  was  used  to  evaluate  the  relationship
between  the  distribution  of  failures  and  age,  BMI,  incli-
nation  of  the  acetabular  cup  and  neck-shaft  angle  of  the
femoral  component.
hening  or  lateral  offset  of  the  joint).  A.  On  the  femoral  side,
e  average  medialization  was  −2.4  mm  (range  −31  to  23  mm).
e  acetabular  side,  the  average  upward  migration  was  −1.3  mm
to  9  mm).  The  average  cup  inclination  was  44.4◦ (range  30  to
easurement  was  5  mm  (range  0  to  15  mm).
2 S.  Leclercq  et  al.
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Figure  2  Implant  survival  after  5  years  with  surgical  revision
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Survival  curves  were  generated  based  on  the  Kaplan-
eier  method.  The  main  failure  criterion  was  implant
emoval.  The  survival  analysis  was  also  performed  while
peciﬁcally  including  the  tilt  of  the  acetabular  cup,  neck
racture,  necrosis  and  all  the  re-operations.  Differences  in
mplant  survival  between  the  various  participating  centres
ere  detected  with  a  log-rank  test.  The  impact  of  the  learn-
ng  curve  was  evaluated  by  comparing  the  survival  of  the  ﬁrst
0  cases  from  each  surgeon  with  the  survival  in  the  following
ases  using  the  log-rank  test.
esults
ith  an  average  follow-up  of  34  months  (range  12—102),  549
atients  had  not  been  operated  on  again  (613  hips).  All  these
atients  had  been  reviewed  in  the  two  years  leading  up  to
he  study,  with  a  full  clinical  and  radiological  analysis.  From
he  initial  cohort,  31  patients  (4.8%)  were  re-operated  at
n  average  of  36.3  months  (range  0—72.5)  after  the  initial
rocedure,  for  the  following  reasons  (Table  2):
 10  cases  (1.6%)  of  femoral  neck  fractures,  with  ﬁve  occur-
ring  during  the  ﬁrst  year  and  ﬁve  occurring  during  the
second  year.  Of  these  10  femoral  component  fractures,
seven  had  been  implanted  using  a  Rottinger-type  antero-
lateral  approach  in  the  same  centre;
 12  cases  (1.9%)  of  femoral  loosening  that  had  occurred  an
average  of  15.3  months  (range  1—40.9)  after  the  initial
procedure  and  had  an  undetermined  cause  (head  collapse
or  deterioration  of  the  bone-cement  or  implant-cement
interface).  Four  of  these  had  been  implanted  with  a  lat-
eral  approach  and  eight  with  a  posterolateral  approach.
Loosening  occurred  during  the  ﬁrst  year  in  ﬁve  cases,  dur-
ing  the  second  year  in  two  cases,  third  year  in  three  cases,
and  during  the  ﬁfth  and  sixth  year  in  the  other  two  cases;
 four  cases  (0.6%)  of  early  tilting  of  the  acetabular  cup,
which  were  revised  at  one  month  (range  0—1.6)  on  aver-
age;
 one  case  (0.2%)  of  an  adverse  reaction  to  metal  debris,
which  occurred  at  72.5  months;
 three  cases  (0.5%)  of  unexplained  groin  pain  that  required
re-operation  after  an  average  follow-up  of  6.3  months
(range  1.4—13.2);
 one  case  (0.2%)  of  deep  infection  at  two  years  post-
surgery.
Dislocation  occurred  once  in  four  patients  (four  hips)
ith  no  recurrence  (0.6%).  These  four  patients  had  all  been
perated  on  by  the  same  surgeon  using  the  Hardinge  antero-
ateral  approach.  A  systematic  misalignment  was  found,
ith  excessive  acetabular  anteversion  visible.
In  the  549  patients  who  were  not  re-operated,  the  aver-
ge  preoperative  PMA  score  of  11  (range  6—16)  improved
o  17.2  (range  12—18)  at  the  last  follow-up  and  the  WOMAC
core  was  91  (range  20—100).  The  average  Devane  activity
core  went  from  2.2  (range  1—5)  to  3.8  (range  2—5).Radiographic  analysis  of  these  549  patients  revealed  28
ases  (5.1%)  of  femoral  neck  narrowing,  two  cases  (0.4%)
f  acetabular  radiolucent  lines  and  three  cases  (0.6%)  of
adiolucent  lines  around  the  femoral  stem.  There  were  no
i
m
r
dor any  reason  taken  as  the  end  point:  91%  (95%  conﬁdence
nterval:  87—94%).
ontinuous  radiolucent  lines  over  all  the  areas,  nor  was  a
hange  in  implant  position  observed.
The  acetabular  cup  was  medialized  by  an  average  of
.7  mm  (range  −15  to  9  mm)  when  compared  to  the  con-
ralateral  hip.  The  centre  of  rotation  had  moved  upwards
y  an  average  of  1.3  mm  (range  −26  to  9  mm)  (Fig.  1B).
he  average  acetabular  cup  inclination  was  44.4◦ (range
0—70◦).  The  average  femoral  neck-shaft  angle  before  the
urgery  was  134.4◦ (range  110—146◦);  the  average  angle
etween  the  stem  of  the  femoral  head  and  the  shaft  axis
as  138.9◦ (range  112—158◦) after  the  surgery  (Fig.  1A).  The
emoral  offset  relative  to  the  contralateral  hip  was  reduced
y  an  average  of  2.4  mm  (range  −31  to  23)  (Fig.  1C).  The  leg
as  longer  by  an  average  of  0.8  mm  (range  −15  to  19).  The
verage  anterior  offset  was  5  mm  (range  0  to  15  mm).  The
verage  diameter  of  the  implanted  femoral  head  was  48  mm
range  38—58).
Gender,  age  and  BMI  had  no  effect  on  the  risk  of  failure
P  >  0.05).  The  type  of  surgical  approach  varied  by  centre,
ith  the  posterolateral  approach  being  used  most  often
P  =  0.001).  The  revision  rate  was  higher  in  the  centres
sing  the  anterolateral  approach;  use  of  this  approach  also
esulted  in  a  higher  revision  rate  than  use  of  the  posterolat-
ral  approach  (P  =  0.002)  (Table  2).
For  the  entire  series,  when  the  end  point  was  surgical
evision  with  the  implant  removed  for  any  reason,  the  5-year
urvival  rate  was  91.2%  (95%  conﬁdence  interval:  87—94%)
Fig.  2).  The  results  ranged  from  90  to  100%,  depending  on
he  centre.  One  centre  (with  a  single  surgeon)  had  a  signif-
cantly  greater  implant  survival  rate  (P  =  0.001).  The  other
entres  (with  multiple  surgeons)  had  homogeneous  results.
iscussion
he  main  advantages  of  hip  resurfacing  with  second-
eneration  metal-on-metal  bearings  are  the  ability  to
reserve  the  femoral  bone  (making  future  revision  eas-
er),  good  stability,  preservation  of  joint  biomechanics  and
inimal  wear  of  the  bearing  surfaces.  This  design  was
eintroduced  by  the  industry,  with  various  implants  having
ifferent  features.  The  goal  of  this  study  was  to  evaluate
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the  radiological  and  clinical  results,  complication  rate  and
short-term  survival  of  the  Durom  implant  and  to  compare
these  aspects  to  historical  results  with  traditional  total  hip
arthroplasty  (THA)  and  other  commercially  available  resur-
facing  systems.
But  the  current  study  has  a  number  of  limitations.
First,  we  described  a  retrospective  case  series  with-
out  a  control  group.  Thus  comparisons  with  traditional
THA  and  other  resurfacing  implants  may  be  subject
to  bias.  Multiple  surgical  approaches  were  used,  thus
it  was  difﬁcult  to  draw  any  conclusions  about  implant
positioning.  The  follow-up  was  relatively  short,  which  lim-
its  the  conclusions  that  can  be  drawn,  especially  since
these  implants  were  developed  for  young  subjects  with
a  long  life  expectancy.  Excellent  long-term  performance
will  be  needed  to  truly  determine  the  value  of  this
implant.
Our  multicentre  clinical  evaluation  of  the  Durom  implant
found  functional  results  that  were  as  good  as  those  achieved
with  traditional  total  hip  arthroplasty,  as  the  average  PMA
score  was  very  high  [25].  However,  the  short-term  (5-year)
revision  rate  was  higher  than  published  and  National  Regis-
ter  data  with  a  traditional  THA  or  other  resurfacing  implants
[26].  In  addition,  the  functional  score  in  the  PMA  is  not  sen-
sitive  enough  to  demonstrate  a  difference  in  young,  active
subjects  [9,27].  New,  more  appropriate  outcome  measures
seem  to  be  needed.
The  survival  rate  for  traditional  arthroplasty  (no  matter
the  age  or  aetiology)  ranges  from  96—98%  at  10  years  [26].
Hip  resurfacing  is  used  in  a  relatively  young  population  —
in  our  series,  the  average  patient  age  was  50  years.  The
results  of  traditional  arthroplasty  in  younger  subjects  are
not  the  same  as  in  older  subjects.  In  patients  below  50  years
of  age,  the  reported  10-year  survival  rate  is  between  85  and
95%  [28,29].  For  even  younger  subjects  (under  30  years  of
age),  the  survival  rate  drops  to  below  60%  at  the  10-year
follow-up  [30—32].  For  hip  resurfacing,  many  groups  have
reported  a  5-year  survival  rate  around  95%  [5,7,24].  In  young
patients  (under  30  years  of  age),  a  100%  survival  rate  was
reported  but  the  follow-up  was  less  than  5  years  [33]. Thus
it  seems  that  for  a  young  population,  the  survival  rate  for
a  resurfacing  implant  is  very  close  to  that  of  a  traditional
THA,  which  is  consistent  with  data  from  our  series  (5-year
rate  between  90  and  100%,  depending  on  the  centre).  But
this  rate  was  worse  because  of  complications  speciﬁc  to  the
Durom  implant,  such  as  early  implant  tilting  [27],  which  was
observed  in  1%  of  cases  with  this  same  implant  [34]. This
occurred  more  often  than  with  the  Birmingham  hip  resur-
facing  system  because  the  bone  ingrowth  is  not  as  good
[27].  A  Swiss  group  reported  a  survival  rate  of  88.2%  in
a  series  of  100  Durom  resurfacing  cases  with  an  average
follow-up  of  60  months  [34].  The  Durom  implant  results
were  slightly  worse  than  those  reported  with  other  commer-
cially  available  resurfacing  implants  [35,36].  Although  each
implant  has  its  own  speciﬁc  characteristics,  each  requires
the  same  set  of  favourable  conditions:  well-trained  surgeon,
acetabular  cup  inclination  less  than  45◦ and  consistent  with
anatomical  anteversion,  femoral  head  with  5◦ valgus  rela-
tive  to  the  neck-shaft  angle,  which  covers  the  entire  area  of
reamed  bone,  no  notching  in  the  neck  and  male  patient  hav-
ing  osteoarthritis  and  femoral  head  diameter  greater  than
48  mm  [4,33].
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In  our  series,  the  neck  fracture  rate  was  1.6%  (from  0  to
.6%,  depending  on  the  centre)  and  was  closely  related  to
he  anterolateral  surgical  approach.  Half  the  neck  fractures
ere  caused  by  a  high-energy  trauma.  Femoral  neck  fracture
s  a  complication  that  is  particular  to  resurfacing.  It  most
ften  occurs  during  the  ﬁrst  year.  The  frequency  is  rarely
bove  2%  [37].  Small  size,  cup  varus,  superior  neck  notching
nd  increase  in  femoral  offset  were  identiﬁed  as  risk  factors
38]. Surgeon  experience  is  also  an  important  factor  since
he  fracture  rate  was  2.5%  in  the  ﬁrst  69  cases  and  then  was
.4%  later  on  [39].  This  was  also  supported  by  our  ﬁndings
n  the  single-surgeon  centre.
The  rate  of  femoral  component  loosening  in  our  series
as  1.9%  (from  0  to  3%,  depending  on  the  centre),  which
ompares  to  the  2%  rate  reported  by  others  with  this  same
mplant  [34].  Failure  at  the  femoral  interface  can  be  sec-
ndary  to  necrosis  of  the  residual  femoral  head  bone  or  to
 fracture  of  the  cement  mantle.  Loosening  secondary  to
ecrosis  typically  occurs  during  the  ﬁrst  few  months  after
urgery  and  seems  to  be  directly  related  to  devasculariza-
ion  of  the  femoral  head.  Femoral  head  necrosis  was  found
n  88%  of  revisions  after  hip  resurfacing,  with  no  effect  of
he  surgical  approach  [40].  Resorption  of  the  femoral  neck
ver  multiple  areas  seems  to  be  indicative  of  head  necrosis.
emoral  loosening  later  on  could  be  the  result  of  cement
ailure  due  to  repeated  microscopic  trauma.  The  ability
f  the  cement  to  withstand  fatigue  depends  on  its  quality
number  of  impurities  such  as  air  bubbles)  and  its  thickness.
he  surgical  technique  for  the  Durom  implant  allows  for  a
airly  thick  (0.75  to  1  mm)  layer  of  cement.  The  depth  of
he  cement  penetration  into  the  bone  must  also  be  taken
nto  consideration.  The  Durom  implant  has  internal  grooves
hat  facilitate  cement  extravation  and  reduce  the  pressure
uring  insertion.  Beaulé  et  al.  have  observed  less  penetra-
ion  of  the  cement  into  the  bone  with  the  Durom  implant
han  with  the  BHR  system  [41]. The  possibility  of  implanting
ementless  femoral  components  could  resolve  this  variabil-
ty  in  cementing  technique  [42].
We  observed  a  low  risk  of  complications  such  infection,
evision  for  groin  pain  and  reaction  to  the  metal-on-metal
earing.  We  found  only  one  case  of  reaction  to  metal  wear
ebris  (0.15%),  which  can  be  attributed  to  the  good  tribo-
ogical  performance  of  the  Durom  implant  and  is  consistent
ith  the  low  levels  of  metal  ions  released  [9].  Based  on  data
n  this  study,  we  could  not  conﬁrm  the  typically  reported
isk  factors  for  metal-on-metal  bearing  reactions  such  as
emale  gender,  small  implant  size  and  wrong  implant  posi-
ion  [43]. Similarly,  we  found  a  very  low  rate  of  revision
or  groin  pain  (0.5%)  [44].  Female  gender,  young  age  and
ctivity  level  were  identiﬁed  as  risk  factors  for  groin  pain
45]. A  study  comparing  traditional  THA,  hip  resurfacing
nd  large-diameter  femoral  head  THA  found  no  signiﬁ-
ant  differences  in  the  rate  of  groin  pain  between  the
hree  groups  after  a  2-year  follow-up  [46]. We  observed
 0.15%  infection  rate.  Since  no  studies  have  been  per-
ormed  comparing  THA  and  resurfacing,  no  conclusions  can
e  drawn  about  differences  in  the  infection  rate  between
he  two  techniques.  The  infection  rate  following  primary
HA  ranges  from  0.5  to  2.2%  [47,48].  A multicentre  study
eported  an  infection  rate  of  0.5%  (3/653)  after  resurfac-
ng  [49],  which  has  been  conﬁrmed  in  another  study  (0.6%)
50].
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In  the  current  study,  the  dislocation  rate  of  0.6%  was  cor-
elated  to  the  anterolateral  surgical  approach  (from  0  to
%,  depending  on  the  surgeon);  none  of  these  dislocations
equired  a  new  procedure  to  be  performed.  The  large  fric-
ion  diameter  in  theory  helps  to  limit  the  risk  of  dislocation,
ven  if  the  retaining  ability  of  the  acetabular  cup  is  not  as
reat  as  with  a  dual  mobility  implant.  The  dislocation  risk
s  typically  zero,  although  one  study  reported  a  rate  of  2.2%
50].
onclusion
esults  with  a  second-generation  hip  resurfacing  system
eem  to  be  encouraging.  Our  multicentre  clinical  evaluation
f  the  Durom  implant  showed  functional  and  activity-related
esults  that  are  comparable  to  those  achieved  with  tra-
itional  THA.  However,  the  revision  rate  was  higher  than
n  published  and  National  Register  data  using  traditional
HA  or  other  resurfacing  implants.  These  differences  can
e  explained  by  the  design  and  geometry  of  the  cup,  which
ake  it  difﬁcult  to  insert  and  results  in  poor  primary  ﬁx-
tion,  along  with  the  high  rate  of  femoral  neck  fracture
nd  dislocation  when  an  anterolateral  surgical  approach  was
sed.
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